Introduction: Who Should Undergo Diagnostics

If you have been diagnosed with advanced liver disease, particularly cirrhosis—which is permanent scarring of the liver—you should be aware that your kidneys may also be at risk. Hepatorenal syndrome develops when severe liver problems affect the blood vessels in your kidneys, causing them to narrow and reducing blood flow. This leads to kidney failure even though the kidneys themselves have no structural damage.^[1]

You should seek diagnostic testing if you notice a decrease in how often you urinate, especially if you already have symptoms of liver disease such as a swollen belly, yellowing of your skin or eyes, confusion, or unusual tiredness. People who are hospitalized with liver failure should be monitored closely, as up to 10% of them may develop hepatorenal syndrome. Those with conditions like ascites—fluid buildup in the abdomen—or those who have had infections such as spontaneous bacterial peritonitis are at particularly high risk and need regular checks.^[2][3]

It is especially important to undergo diagnostics if you experience sudden changes in your health while dealing with chronic liver disease. For instance, if you develop gastrointestinal bleeding, if you are taking water pills called diuretics and notice worsening symptoms, or if you develop an infection in the fluid around your abdomen, these could all trigger kidney problems. Approximately one-third of people who have spontaneous bacterial peritonitis go on to develop hepatorenal syndrome, which is why prompt evaluation is essential.^[1]

If you are on a waiting list for a liver transplant or if your doctor suspects your kidneys are not working properly, you will need diagnostic tests to confirm whether hepatorenal syndrome is present. The sooner this condition is identified, the sooner treatment can begin to protect your kidneys and prepare you for potential transplantation.^[2]

Diagnostic Methods to Identify Hepatorenal Syndrome

Diagnosing hepatorenal syndrome is not straightforward because there is no single test that can definitively confirm it. Instead, doctors use a process of elimination. They first confirm that you have both liver disease and kidney failure, and then they work to rule out other possible causes of kidney problems. This approach is necessary because the kidneys in hepatorenal syndrome look normal under a microscope—the failure is functional, not structural.^[1][2]

Physical Examination

Your doctor will start by examining you for signs of advanced liver disease. They will look for jaundice, which is a yellowing of your skin and the whites of your eyes caused by a buildup of a substance called bilirubin. They will also check for a swollen abdomen, which may be due to fluid accumulation known as ascites, an enlarged liver, or an enlarged spleen. Other signs include confusion or disorientation, easy bruising, itchy skin, and changes in the color of your urine and stool.^[2][7]

The doctor will also assess your blood pressure, particularly whether it drops when you stand up quickly—a condition called orthostatic hypotension. They may check for signs of fluid retention in your legs or abdomen and look for abnormal reflexes or cognitive changes that indicate liver-related brain dysfunction known as hepatic encephalopathy.^[6][7]

Blood Tests

Blood tests are essential to understand how well your kidneys and liver are functioning. The most important marker for kidney function is serum creatinine, a waste product that builds up when your kidneys are not working properly. In hepatorenal syndrome, doctors look for a significant rise in creatinine levels—specifically, an increase of at least 0.3 milligrams per deciliter within 48 hours, or a doubling of creatinine from your baseline reading.^[3][6]

Another important blood test measures blood urea nitrogen, or BUN, which also rises when the kidneys fail. Doctors will also check your blood sodium levels, as people with hepatorenal syndrome often have low sodium, a condition called hyponatremia. Low sodium is especially common in those with advanced cirrhosis and is a warning sign that hepatorenal syndrome may develop.^[1][7]

Liver function tests are performed to assess the severity of liver disease. These include measuring prothrombin time, which indicates how well your blood clots; serum albumin, a protein made by the liver that may be low in liver disease; and sometimes serum ammonia, which can be elevated and contribute to confusion. These tests help doctors understand the full picture of liver failure.^[6][7]

Urine Tests

Urine tests are crucial for distinguishing hepatorenal syndrome from other types of kidney failure. In hepatorenal syndrome, the kidneys try to conserve water and sodium because the body senses low blood volume. As a result, urine tests show very low sodium concentration—typically less than 10 milliequivalents per liter. The urine also becomes more concentrated, with an increased specific gravity and osmolality.^[6][7]

Importantly, in hepatorenal syndrome, there is typically no proteinuria, which means protein is not found in the urine. This absence of protein helps doctors rule out primary kidney diseases such as glomerulonephritis or other conditions that directly damage the kidneys. The volume of urine produced is also measured; people with hepatorenal syndrome often produce very little urine, a condition called oliguria—usually less than 500 milliliters per day.^[1][6]

Imaging Studies

Imaging tests help doctors visualize the liver, kidneys, and related structures to rule out blockages or structural problems. An abdominal ultrasound is commonly used to check for signs of cirrhosis, ascites, and to assess kidney size and appearance. In hepatorenal syndrome, the kidneys usually look normal on ultrasound, which helps confirm that the kidney failure is functional rather than due to physical damage.^[6][7]

Ultrasound can also detect portal hypertension, which is high blood pressure in the vein that carries blood to the liver. This is a key factor in the development of hepatorenal syndrome. In some cases, doctors may use more advanced imaging such as a CT scan to get a detailed view of the liver and kidneys and to rule out tumors, blood clots, or other complications.^[6]

Ruling Out Other Causes

A critical part of diagnosing hepatorenal syndrome is excluding other reasons for kidney failure. Doctors must rule out conditions like acute tubular necrosis, which is kidney damage from toxins or lack of blood flow; kidney infections; obstruction of the urinary tract; and the use of medications that harm the kidneys, such as nonsteroidal anti-inflammatory drugs (NSAIDs) or certain antibiotics.^[2][7]

To do this, doctors may review your medication history, check for signs of infection, and sometimes perform additional tests like a kidney biopsy if there is uncertainty. However, kidney biopsies are not commonly performed in hepatorenal syndrome because the kidneys appear normal under the microscope, and the procedure carries risks in people with severe liver disease.^[1]

Classification by Severity

Once hepatorenal syndrome is diagnosed, doctors classify it based on how quickly the kidney failure has developed. There are two main types. Type 1 hepatorenal syndrome, now often called HRS-AKI (acute kidney injury), is characterized by a rapid decline in kidney function, with creatinine doubling to at least 2.5 milligrams per deciliter in less than two weeks. This type progresses quickly and is often triggered by infections or bleeding.^[3][6]

Type 2 hepatorenal syndrome, or HRS-NAKI (non-acute kidney injury), is slower and more gradual. It is typically associated with refractory ascites—fluid in the abdomen that does not respond to diuretics. This form progresses over weeks to months rather than days.^[3][6]

The classification helps guide treatment decisions and gives doctors and patients a clearer understanding of the urgency and prognosis of the condition.^[3]

Diagnostics for Clinical Trial Qualification

If you are considering participating in a clinical trial for hepatorenal syndrome, you will need to undergo specific diagnostic tests to determine whether you meet the eligibility criteria. Clinical trials are research studies that test new treatments or approaches to managing diseases, and they require precise measurement of your condition to ensure the trial results are accurate and meaningful.

To qualify for most hepatorenal syndrome clinical trials, doctors will first confirm that you have advanced liver disease, typically cirrhosis with portal hypertension and ascites. This is usually established through a combination of physical examination, blood tests showing impaired liver function, and imaging studies such as ultrasound or CT scans that reveal cirrhosis and fluid accumulation.^[1][2]

A key requirement for enrollment in clinical trials is documented kidney failure that meets the definition of hepatorenal syndrome. This means your serum creatinine must have risen to a specific level—often at least 1.5 milligrams per deciliter or higher—and the increase must have occurred over a defined period. For trials focused on acute kidney injury, the creatinine rise must be rapid, typically within 48 hours to two weeks.^[3][6]

Urine tests are also critical for trial qualification. Your urine sodium concentration must be very low, typically less than 10 milliequivalents per liter, to confirm that your kidneys are conserving sodium as expected in hepatorenal syndrome. Additionally, your urine output may be measured over 24 hours to determine if you are producing less than 500 milliliters per day, which indicates oliguria.^[6][7]

Doctors must also rule out other causes of kidney failure before you can be enrolled in a trial. This involves confirming that you have not used nephrotoxic medications—drugs that can harm the kidneys—such as NSAIDs, certain antibiotics, or intravenous contrast dyes used in imaging. You will also be checked for urinary tract obstruction, kidney infections, and shock, all of which can cause kidney failure unrelated to hepatorenal syndrome.^[2][7]

Clinical trials may require additional baseline tests to monitor your overall health and response to treatment. These can include more detailed liver function tests, blood clotting studies, and tests for infections such as spontaneous bacterial peritonitis. Some trials may also require imaging studies to assess blood flow in the liver and kidneys or to detect complications like blood clots.^[6]

In some trials, especially those testing new medications, you may need to undergo regular follow-up tests to track changes in your kidney and liver function. This can include repeated blood tests to measure creatinine, urea, sodium, and albumin levels, as well as urine tests to monitor sodium excretion and urine volume. These measurements help researchers understand whether the treatment is working and whether it is safe.^[9]

If the clinical trial involves procedures such as dialysis, transjugular intrahepatic portosystemic shunt (TIPS), or liver transplantation, additional diagnostic evaluations will be needed. For example, before placing a TIPS—a procedure that creates a channel within the liver to reduce portal hypertension—doctors will assess your liver function using scoring systems and imaging to ensure you can safely undergo the procedure.^[14][9]

Finally, clinical trials often require documentation of your eligibility for liver transplantation, as this is the definitive treatment for hepatorenal syndrome. This may involve tests to evaluate your overall health, assess your heart and lung function, and confirm that you do not have conditions that would prevent transplantation, such as active cancer or severe infections.^[2]

Participating in a clinical trial can provide access to cutting-edge treatments and contribute to medical knowledge that helps others in the future. However, it is important to discuss with your doctor whether a trial is appropriate for your specific situation and to understand the diagnostic requirements and potential risks involved.